SGS proderm
Dr. Carolin Mull is an experienced Clinical Trial Project Manager currently at SGS proderm since November 2023. Previously, Dr. Mull held roles as Clinical Affairs Manager at EUROIMMUN and Tiplu GmbH, and as Projektmanager in Clinical Operations at proderm GmbH. Dr. Mull has significant experience in research, having served as Forschungsleiterin at Asklepios Klinik Hamburg St. Georg and as a scientific employee in cell and molecular biology at Metavectum. Earlier academic contributions include a postdoctoral researcher in tumor biology at Universitätsklinikum Hamburg Eppendorf, along with a doctoral degree in tumor biology focusing on circulating tumor cells. Dr. Mull's educational background includes a Master of Science in Regulatory Affairs from Technische Hochschule Lübeck and a Diplom-Ingenieurin in Biotechnology from Hamburg University of Applied Sciences.
This person is not in any teams
SGS proderm
SGS proderm is the globally renowned contract research institute for dermatology. A highly motivated and capable team of over 100 study experts, over 20 medical specialists and over 25 years of experience serve as the basis for competent management of all tasks and studies involving the skin and mucous membrane. This also applies for all products, regardless of regulatory conditions – from cosmetics to medicines. Every year, we test the tolerance and effectiveness of more than 2,000 cosmetic products by renowned manufacturers; we also successfully complete necessary studies for approval of more than five medicines and medical devices. Our ambition? Excellence.